New drug development : science, business, regulatory, and intellectual property issues cited as hampering drug development efforts : report to congressional requesters /

Federal taxation of the drug industry and its effects on new drug development /
by: Guenther, Gary
Published: (2019)

Drug shortages : FDA's ability to respond should be strengthened : report to congressional requesters.
Published: (2011)

FDA drug bulletin.
Published: (1971)

FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics /
Published: (2004)

Development and evaluation of drugs : from laboratory through licensure to market /
by: Lee, Chi-Jen
Published: (2003)

Drugs@FDA.

Optimizing the "drug-like" properties of leads in drug discovery /
Published: (2006)

Drug Listing Act of 1972.
Published: (1972)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

The Food and Drug Administration's process for approving new drugs : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.
Published: (1979)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

Prescription drugs : FDA's oversight of the promotion of drugs for off-label uses : report to the Ranking Member, Committee on Finance, U.S. Senate.
Published: (2008)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)

Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981.
Published: (1983)

The future of drug safety : promoting and protecting the health of the public /
Published: (2007)

Drug safety : better data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters.
Published: (2008)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)

The Food and Drug Administration /
by: Patrick, William
Published: (1988)

Prescription Drugs : FDA Guidance and Regulations Related to Data on Elderly Persons in Clinical Drug Trials.
Published: (2007)

Drug discovery and development /
Published: (2006)

Pharmaceutical biotechnology in drug development /
by: Akash, Muhammad Sajid Hamid, et al.
Published: (2023)

Drug compounding for animals : FDA could improve oversight with better information and guidance : report to congressional committees.
Published: (2015)

Nonprescription drugs : considerations regarding a behind-the-counter drug class : report to congressional requesters.
Published: (2009)

Nonprescription drugs : considerations regarding a behind-the-counter drug class : report to congressional requesters.
Published: (2009)

Drug shortages : FDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate /
by: Crosse, Marcia
Published: (2011)

El proceso del desarrollo de las drogas y la FDA : cómo la agencia asegura que las drogas sean seguras y efectivas.
Published: (2002)

The Orphan Drug Act and Catalyst Pharmaceuticals, Inc., v. Becerra /
by: Rogers, Hannah-Alise
Published: (2023)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Drug metabolism in drug design and development : basic concepts and practice /
Published: (2008)

Burger's medicinal chemistry, drug discovery and development /
Published: (2010)

Drug Industry Antitrust Act : hearings before the United States House Committee on the Judiciary, Subcommittee on Antitrust, Eighty-Seventh Congress, second session, on May 17, 18, 23, 24, 1962.
Published: (1962)

Drugs in the Development Pipeline : Impact on Part B Medicare Spending.
Published: (2003)

Biopharmaceutics applications in drug development /
Published: (2008)

Drug pricing and intellectual property : the legislative landscape for the 117th Congress /
by: Hickey, Kevin J., et al.
Published: (2021)

Fundamentals of drug development /
by: Barrett, Jeffrey S.
Published: (2022)